Switching to doravirine maintains viral suppression in HIV-1

In patients with HIV-1 infection, switching from etravirine-containing antiretroviral therapy (ART) to doravirine-containing ART maintained viral control with 91.7% success rate at 48 weeks and demonstrated good tolerability even in patients with…